Comparison of Atezolizumab plus Aevacizumab and Atezolizumab plus Aabozantinib for advanced hepatocellular carcinoma: A cost-effectiveness analysis - Heng Xiang; Zhihua She; Liting Wang; Ye Peng; Lei Zhang; Chongqing Tan (PLoS ONE, 2025)